Based on our earlier findings that Ebi3 could attenuate inflammatory intensity by inducing Tr1 cells after T. cruzi infection, we evaluated whether the treatment of T. cruzi-infected Ebi3-deficient mice with anti-IFN-γ MAb could control myocarditis and improve host survival. Here, EBI3 is linked to myocarditis.